All these data together indicate that the overexpression of LOX potentially facilitates tumor progress and leads to a worse prognosis for patients with gastric cancer by promoting M2 macrophage polarization, which then activates a series of downstream cancer-promoting signaling pathways. The gene discussed is LOX; the disease is cancer.